CPA
NRC icon

Capital Performance Advisors’s NRC Health Common Stock NRC Stock Holding History

Capital Performance Advisors’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4
Closed -$91 – 1800
2024
Q3 		$91 Buy
+4
New +$90 ﹤0.01% 2714

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Performance Advisors's NRC Position: Q4 2024 in Review

Capital Performance Advisors sold out of NRC Health Common Stock (NRC) in Q4 2024, closing a stake of 4 shares — an estimated $91 sold.

Capital Performance Advisors first reported a position in NRC in Q3 2024 and held it in 1 quarter. The position peaked at $91 in Q3 2024. 133 funds tracked by Wall St. Rank hold NRC as of Q4 2024.

  • Capital Performance Advisors reported no remaining NRC Health Common Stock position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 4 NRC Health Common Stock shares in Q4 2024, an estimated $91.
  • Capital Performance Advisors first reported a position in NRC Health Common Stock in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's NRC Health Common Stock position peaked at $91 in Q3 2024.
  • 133 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.